Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK/PD of NNC0472-0147 in Healthy Subjects and Type 2 Diabetes
NCT04262661Phase 1Completed
- Sponsor
- Novo Nordisk
- Start
- Mar 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of NNC0472-0147 in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Novo Nordisk. Primary endpoint: Number of treatment emergent adverse events. Started Mar 2020; status: completed.
02
Drugs
NNC0472-0147
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04262661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04262661.